Seattle Genetics, Inc (NASDAQ:SGEN) Impressed After Receiving Positive Data For Adcetris

Seattle Genetics, Inc (NASDAQ:SGEN) and Takeda Pharmaceutical Company Limited are the main newsmakers today after they announce positive results in regards to the phase III study, ECHLEON 1 study. It was set up in a bid to evaluate Adcetris (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in the different persons diagnosed with […]

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) Provides Positive Update on ProscaVax Data

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) has been one of our favorite new players in the $7.1 billion prostate cancer treatment market. The company just put out a new press release summarizing data that makes a strong case in the preparation of a coming Phase II trial of ProscaVax, which is OncBioMune’s lead pipeline asset. As noted […]

A New Angle To The Latest Endocyte, Inc. (NASDAQ:ECYT) Story

Boston, MA 03/21/2014 (wallstreetpr) – Endocyte, Inc. (NASDAQ:ECYT) announced that its lung cancer drug candidate showed positive results in patients during the mid-stage study. The company also announced recommendation for the use of the drug in the treatment of ovarian cancer patients in Europe. Shares of the company gained significantly on the back of the positive […]